https://www.gabarx.com/2022/10/02/gaba-therapeutics-completes-single-ascending-dose-sad-stage-of-phase-1-study-in-grx-917-in-melbourne/ Mon, 29 Jul 2024 22:15:28 +0000 hourly 1